Clinical Validation of the M5L Lung CAD

Candiolo Cancer Institute - IRCCS

Status: Completed

Conditions: Lung Cancer Metastatic

Treatments: Diagnostic Test: Computed Tomography

Study type: Observational

Funder types: Other

Identifiers

NCT03179150

35/2017 CADM5L

Details and patient eligibility

About

To compare the diagnostic performance and time efficiency of Computer-Aided Detection (CAD) assisted reading for the identification of pulmonary nodules in chest Computed Tomography (CT) from oncological patients with that of unassisted reading.

Full description

The main aim of this study is to compare the diagnostic performance of CAD assisted interpretation with that of unassisted reading in the detection of lung metastases in consecutive patients staged for extrathoracic malignancies. This study also aims at validating a new Web/Cloud based workflow for the use of CAD systems in clinical practice, not requiring installation of additional software or hardware and potentially representing a cost-effective CAD solution for clinical facilities.

Enrollment: 237 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed extra-thoracic neoplasm

Exclusion criteria

• More than 10 nodules
• Severe pulmonary fibrosis
• Diffuse bronchiectasis
• Extensive inflammatory consolidation
• Massive pleural effusion
• Pregnancy

Trial design

237 participants in 1 patient group

Oncological patients with extra-thoracic cancer

Description:

Patients enrolled into the study performed CT either for staging, restaging or follow-up of extrathoracic malignancies.

Treatment:

Diagnostic Test: Computed Tomography